DEEPTHI KRISHNA: Open Payments
NPI 1235910126 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,164 in 27 payments from 12 companies in 2025. Trend: 2023 $845 · 2024 $1,028 · 2025 $1,164
Food & beverage: $1,032Education: $132
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $191 |
| Amgen Inc. | 4 | $191 |
| Madrigal Pharmaceuticals | 1 | $147 |
| Alnylam Pharmaceuticals Inc. | 1 | $135 |
| Grifols USA, LLC | 1 | $125 |
| PFIZER INC. | 1 | $125 |
| ABBVIE INC. | 4 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $70 |
| Axsome Therapeutics, Inc. | 1 | $35 |
| Almatica Pharma LLC | 1 | $24 |
Products named: TREMFYA, REZDIFFRA, GIVLAARI, Prolastin-C Liquid, KRYSTEXXA, XELJANZ, OTEZLA, SAPHNELO.
Industry payments across NY — which companies pay providers there.
